PET/CT helps predict mortality in metastatic breast cancer patients

09/14/2011 | (free registration)

Researchers at last week's American Society of Clinical Oncology Breast Cancer Symposium reported that in breast cancer patients with bone metastases, higher standardized uptake values on PET/CT scans could indicate greater risk of death. Prognostication for metastatic breast cancer has been difficult, but modern PET/CT may serve as a "complementary and clinically useful prognostic tool," said researcher Dr. Komal Jhaveri from the Memorial Sloan-Kettering Cancer Center in New York.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX